Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells
Lingchao Miao, Haolin Zhang, Meng Sam Cheong, Ruting Zhong, Paula Garcia‐Oliveira, Miguel Angel Prieto, Ka‐Wing Cheng, Mingfu Wang, Hui Cao, Shaoping Nie, Jesús Simal‐Gándara, Wai San Cheang, Jianbo Xiao
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1016/j.fshw.2023.03.021 ↗
- Volume · Issue · Pages
- 12 · 6 · 1991-2000
- Publisher
- Elsevier BV
- Article URL
- https://doi.org/10.1016/j.fshw.2023.03.021 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
05 Apr 2023
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 05 Apr 2023 | OpenAlex |
Keywords (as given): apigenin; luteolin; baicalein; flavonoids; insulin resistance; PI3K/Akt signaling; GLUT4; GSK3β; glycogen synthesis; reactive oxygen species; advanced glycation end products; NF-κB; IRS-1; insulin receptor substrate 2; HepG2 cells; high glucose; dexamethasone; glucose uptake; anti-diabetic effects
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2022–23.
- Journal
- Food Science and Human Wellness
- Publication date used
- 05 Apr 2023 (OpenAlex publication date)
- Applicable HEC period
- 2022–23 (version 2) · 01 Jul 2022 – 30 Jun 2023
- Category
- X
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- hjrs-2022-23 row 5919
- Verification status
- Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.